TrialInvestigational new drugs2015

First-in-human study of the toxicity, pharmacokinetics, and pharmacodynamics of CG200745, a pan-HDAC inhibitor, in patients with refractory solid malignancies.

Kyu-pyo Kim et al.PubMed ↗Publisher ↗

No numbers read from the abstract.